Answers are grounded in this paper and cite their sources.
Abstract Background With the introduction of RSV immunoprophylaxis, the contribution and severity of other respiratory viruses require a more comprehensive investigation in different patient cohorts. Methods We performed a retrospective study of hospitalized children with laboratory-confirmed respiratory viral infections at a tertiary pediatric center between 2018 to 2024. Clinical characteristics, outcomes, and predictors of severe disease were analyzed. Results Of 35,943 respiratory specimens, 16,866 (46.9%) tested positive for at least one virus. Clinical data from 2,424 hospitalized children were analyzed. RSV primarily affected infants (median age 5 months, IQR 2–29), whereas human metapneumovirus (hMPV) and influenza virus affected older children (median 26 months, IQR 8–54, and 57 months, IQR 23–108; p<0.001). Respiratory support was required in 71% of RSV and hMPV cases versus 46% of influenza virus (p<0.001). PICU admission occurred in 33/352 (9%) of RSV cases, 9/66 (14%) of hMPV cases, and 33/301 (11%) of influenza cases (p>0.05). In adjusted analyses, RSV was associated with higher odds ratios of requiring respiratory support (OR 6.20, 95% CI 4.60–8.85), followed by hMPV (OR 5.90, 95% CI 3.42–11.7). These associations were stronger than those observed for influenza (OR 2.78, 95% CI 2.07–3.92) and parainfluenza viruses (OR 3.15, 95% CI 2.06–5.13). Conclusion RSV remains the leading cause of severe respiratory disease in early childhood, but hMPV is a substantial contributor in older children with comparable severity and should be considered in future prevention strategies.
No takes yet. Share an insight, caveat, or question.
Aykac et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: